Anika Therapeutics, Inc. (NASDAQ: ANIK) reported its financial results for the first quarter of 2025. The company is undergoing a strategic shift, emphasizing its offerings in osteoarthritis pain management and regenerative solutions following divestitures of certain business units.
Key Highlight...